Medicine News and Research

RSS

Penn Medicine and CHOP announce plans with Costa Rica's CCSS for CAR T research

Penn Medicine and Children's Hospital of Philadelphia, who together pioneered the research and development of the world's first personalized cellular therapy for cancer - also known as CAR T cell therapy - have announced plans with Costa Rica's CCSS, or the Caja Costarricense de Seguro Social (Social Security Program), to facilitate CAR T research in Costa Rica.

23 May 2022

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

The Department of Emergency Medicine at Washington University School of Medicine in St. Louis played a key role in investigating the accuracy of many different types of COVID-19 diagnostic tests administered in real-life conditions.

23 May 2022

Novel genetic test enables earlier, more accurate diagnosis of primary immunodeficiency disorders

Primary immunodeficiency disorders (PID) can result in chronic and sometimes life-threatening infections. More than 450 PIDs have been described, but timely and accurate diagnoses remain a challenge.

23 May 2022

Sustained weight loss can help improve semen quality in men with obesity

Men all over the world are suffering from deteriorating semen quality – often referred to as an outright fertility crisis.

23 May 2022

UVA scientists make progress in their longstanding efforts to combat tuberculosis

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization reports.

23 May 2022

Novel AI algorithm developed for assessing digital pathology data

Digital pathology is an emerging field which deals with mainly microscopy images that are derived from patient biopsies.

23 May 2022

NCCN announces the recipients of 2022 awards for oncology champions advancing cancer care

The National Comprehensive Cancer Network today announced the recipients of 2022 awards for both internal and external champions advancing NCCN's mission and helping all people with cancer to live better lives.

23 May 2022

Gabapentin treatment may enhance recovery of movement after a stroke

The drug gabapentin, currently prescribed to control seizures and reduce nerve pain, may enhance recovery of movement after a stroke by helping neurons on the undamaged side of the brain take up the signaling work of lost cells, new research in mice suggests.

23 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

Children who grow up with dogs may have protection from Crohn's disease later in life

Young children who grow up with a dog or in a large family may have some protection later in life from a common inflammatory bowel disease known as Crohn's disease, according to a study to be presented at Digestive Disease Week 2022.

23 May 2022

Medication, lifestyle intervention effective in preventing Type 2 diabetes, but not cardiovascular disease

A lifestyle intervention program of increased physical activity, healthy eating and aiming for weight loss of 7% or more, or taking the medication metformin were effective long-term to delay or prevent Type 2 diabetes in adults with prediabetes.

23 May 2022

Low GI diet could help heart disease patients control their body weight and waistline

Eating low glycemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology.

23 May 2022

Study: Liver transplants from drug overdose donors increased in the pandemic's first year

Liver transplants from drug overdose donors rose significantly in the pandemic's first year, helping keep the number of liver transplants in the U.S. stable despite COVID-19 disruptions, according to a study to be presented at Digestive Disease Week 2022.

23 May 2022

Taste buds can be restrained to enjoy low sodium diet

A taste adaptation intervention lowers salt intake and increases enjoyment of a sodium restricted diet in patients with hypertension, according to a small study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology.

23 May 2022

Cannabis users need higher levels of sedation during gastric endoscopies

Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week 2022.

23 May 2022

Custom caskets for kids look like something you ‘would see in a child’s room’

Calyia Stringer had a smile on her face the day she posed for a photo with a yellow flower in her hand. The toddler beamed with pride as she showed off the bloom before handing it to her godmother, Jatoria Foster.

23 May 2022

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Pfizer-BioNTech COVID-19 vaccine-associated tinnitus was relieved with a brief course of Transcranial Magnetic Stimulation treatment.

23 May 2022

Voice analysis app predicts most cases of worsening heart failure in advance

A voice analysis app used by heart failure patients at home recognizes fluid in the lungs three weeks before an unplanned hospitalization or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

Even safe levels of alcohol consumption may harm the heart

Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Researchers determine whether mutations in the Omicron NTD influence its potential to stimulate myeloid cells and enhance inflammatory cytokine release.

22 May 2022

Medicine News and Research

Penn Medicine and CHOP announce plans with Costa Rica's CCSS for CAR T research

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

Novel genetic test enables earlier, more accurate diagnosis of primary immunodeficiency disorders

Sustained weight loss can help improve semen quality in men with obesity

UVA scientists make progress in their longstanding efforts to combat tuberculosis

Novel AI algorithm developed for assessing digital pathology data

NCCN announces the recipients of 2022 awards for oncology champions advancing cancer care

Gabapentin treatment may enhance recovery of movement after a stroke

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Children who grow up with dogs may have protection from Crohn's disease later in life

Medication, lifestyle intervention effective in preventing Type 2 diabetes, but not cardiovascular disease

Low GI diet could help heart disease patients control their body weight and waistline

Study: Liver transplants from drug overdose donors increased in the pandemic's first year

Taste buds can be restrained to enjoy low sodium diet

Cannabis users need higher levels of sedation during gastric endoscopies

Custom caskets for kids look like something you ‘would see in a child’s room’

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Voice analysis app predicts most cases of worsening heart failure in advance

Even safe levels of alcohol consumption may harm the heart

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News